US Stock MarketDetailed Quotes

PBM Psyence Biomedical

Watchlist
  • 3.460
  • -0.050-1.42%
Close Nov 29 13:00 ET
  • 3.540
  • +0.080+2.31%
Post 17:01 ET
2.92MMarket Cap-12P/E (TTM)

Psyence Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(FY)Mar 31, 2023
(Q2)Sep 30, 2022
(FY)Mar 31, 2022
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,267.39%44.23M
-28.75%173.85K
74.30%3.23M
244K
1.86M
Selling and administrative expenses
10.52%1.8M
-18.16%198.18K
-5.40%1.63M
--242.15K
--1.72M
-Selling and marketing expense
1,046.72%80.6K
--1.08K
-59.86%7.03K
--0
--17.51K
-General and administrative expense
6.02%1.72M
-18.60%197.1K
-4.84%1.62M
--242.15K
--1.7M
Research and development costs
-40.67%954.59K
----
1,072.35%1.61M
--1.85K
--137.24K
Depreciation amortization depletion
--240
----
--0
----
----
-Depreciation and amortization
--240
----
--0
----
----
Other operating expenses
--41.48M
---24.34K
----
----
----
Operating profit
-1,267.39%-44.23M
28.75%-173.85K
-74.30%-3.23M
-244K
-1.86M
Net non-operating interest income expense
-3,369.43%-50.81K
-3,558.92%-27.57K
1.55K
797.0283
0
Non-operating interest income
37.32%2.13K
----
--1.55K
----
--0
Non-operating interest expense
--52.94K
----
--0
----
----
Total other finance cost
----
3,558.92%27.57K
----
---797.0283
----
Other net income (expense)
-25,645.52%-6.87M
-7,006.67%-104.19K
1,276.42%26.91K
-1.47K
-2.29K
Gain on sale of security
-1,247.98%-308.95K
-7,006.67%-104.19K
1,276.42%26.91K
---1.47K
---2.29K
Special income (charges)
---2.18M
----
--0
----
----
-Less：Restructuring and merger&acquisition
--2.46M
----
--0
----
----
-Less:Other special charges
---281.5K
----
----
----
----
Other non- operating income (expenses)
---4.39M
----
----
----
----
Income before tax
-1,495.53%-51.16M
-24.91%-305.6K
-72.55%-3.21M
-244.67K
-1.86M
Income tax
Net income
-1,495.53%-51.16M
-24.91%-305.6K
-72.55%-3.21M
-244.67K
-1.86M
Net income continuous Operations
-1,495.53%-51.16M
-24.91%-305.6K
-72.55%-3.21M
---244.67K
---1.86M
Minority interest income
Net income attributable to the parent company
-1,495.53%-51.16M
-28.35%-314.03K
-72.55%-3.21M
-244.67K
-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,495.53%-51.16M
-28.35%-314.03K
-72.55%-3.21M
-244.67K
-1.86M
Basic earnings per share
-3,008.39%-586.5
-28.35%-1.8479
-72.55%-18.8683
-1.4398
-10.9349
Diluted earnings per share
-3,008.39%-586.5
-28.35%-1.8479
-72.55%-18.8683
-1.4398
-10.9349
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Mar 31, 2024 (Q2)Sep 30, 2023 (FY)Mar 31, 2023 (Q2)Sep 30, 2022 (FY)Mar 31, 2022
Total revenue 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 1,267.39%44.23M -28.75%173.85K 74.30%3.23M 244K 1.86M
Selling and administrative expenses 10.52%1.8M -18.16%198.18K -5.40%1.63M --242.15K --1.72M
-Selling and marketing expense 1,046.72%80.6K --1.08K -59.86%7.03K --0 --17.51K
-General and administrative expense 6.02%1.72M -18.60%197.1K -4.84%1.62M --242.15K --1.7M
Research and development costs -40.67%954.59K ---- 1,072.35%1.61M --1.85K --137.24K
Depreciation amortization depletion --240 ---- --0 ---- ----
-Depreciation and amortization --240 ---- --0 ---- ----
Other operating expenses --41.48M ---24.34K ---- ---- ----
Operating profit -1,267.39%-44.23M 28.75%-173.85K -74.30%-3.23M -244K -1.86M
Net non-operating interest income expense -3,369.43%-50.81K -3,558.92%-27.57K 1.55K 797.0283 0
Non-operating interest income 37.32%2.13K ---- --1.55K ---- --0
Non-operating interest expense --52.94K ---- --0 ---- ----
Total other finance cost ---- 3,558.92%27.57K ---- ---797.0283 ----
Other net income (expense) -25,645.52%-6.87M -7,006.67%-104.19K 1,276.42%26.91K -1.47K -2.29K
Gain on sale of security -1,247.98%-308.95K -7,006.67%-104.19K 1,276.42%26.91K ---1.47K ---2.29K
Special income (charges) ---2.18M ---- --0 ---- ----
-Less：Restructuring and merger&acquisition --2.46M ---- --0 ---- ----
-Less:Other special charges ---281.5K ---- ---- ---- ----
Other non- operating income (expenses) ---4.39M ---- ---- ---- ----
Income before tax -1,495.53%-51.16M -24.91%-305.6K -72.55%-3.21M -244.67K -1.86M
Income tax
Net income -1,495.53%-51.16M -24.91%-305.6K -72.55%-3.21M -244.67K -1.86M
Net income continuous Operations -1,495.53%-51.16M -24.91%-305.6K -72.55%-3.21M ---244.67K ---1.86M
Minority interest income
Net income attributable to the parent company -1,495.53%-51.16M -28.35%-314.03K -72.55%-3.21M -244.67K -1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,495.53%-51.16M -28.35%-314.03K -72.55%-3.21M -244.67K -1.86M
Basic earnings per share -3,008.39%-586.5 -28.35%-1.8479 -72.55%-18.8683 -1.4398 -10.9349
Diluted earnings per share -3,008.39%-586.5 -28.35%-1.8479 -72.55%-18.8683 -1.4398 -10.9349
Dividend per share
Currency Unit USD USD USD USD USD
Audit Opinions Unqualified Opinion with Explanatory Notes -- -- -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data